Evidence map›Paper›PMID 38859975›Full record

ArticleJID innovations : skin science from molecules to population health2024

Diacron-Reactive Oxygen Metabolites Levels Are Initially Elevated in Patients with Bullous Pemphigoid.

Nagie Tozaki, Chisato Tawada, Kayoko Tanaka, Dongjun Im, Keisuke Ueda, Noriko Kato, Hiromu Tsuji, Yuka Yoshie, Maho Matsuo, Naohisa Ichiki and 4 more

Abstract read
In one paragraph

Article in JID innovations : skin science from molecules to population health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nagie TozakiDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Chisato TawadaDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Kayoko TanakaDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Dongjun ImDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Keisuke UedaDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Noriko KatoDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Hiromu TsujiDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Yuka YoshieDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Maho MatsuoDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Naohisa IchikiDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Hirofumi NiwaDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Yoko MizutaniDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
En ShuDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Hiroaki IwataDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ROS are involved in the pathogenesis of bullous pemphigoid (BP), but this involvement has not been fully elucidated. In this study, to further elucidate the pathogenic role of ROS in BP, we examined the results of the diacron-reactive oxygen metabolite test and the biological antioxidant potential test for 16 patients with BP who visited our hospital before being treated with systemic corticosteroids. In the patients with BP, the average diacron-reactive oxygen metabolite levels, expressed in Carratelli units, were significantly reduced at 1 month of treatment (from 335.6 ± 40.3 Carratelli units to 224.7 ± 61.6 Carratelli units,

Indexed as

Bullous pemphigoidDiacron-reactive oxygen metabolitesDibromotyrosineOxidative stressROS

Identifiers

PMID38859975
PMCPMC11163163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.